Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level
暂无分享,去创建一个
H. Möller | J. Bobes | J. Newcomer | C. Correll | S. Leucht | D. Cohen | M. Hert | D. Ndetei | M. Cetkovich-Bakmas | Itsuo Asai | J. Detraux | S. Gautam | R. Uwakwe | MARC HERT | DAN COHEN | JULIO BOBES | MARCELO CETKOVICH‐BAKMAS | STEFAN LEUCHT | DAVID M. NDETEI | JOHN W. NEWCOMER | RICHARD UWAKWE | ITSUO ASAI | HANS‐JURGEN MÖLLER | SHIV GAUTAM | JOHAN DETRAUX | CHRISTOPH U. CORRELL
[1] Jeroen J. Bax,et al. 2007 ESH-ESC Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). , 2007, Blood pressure.
[2] Shah Ebrahim,et al. European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012) , 2012, International Journal of Behavioral Medicine.
[3] S. Fekete,et al. Use of Antipsychotics in the Management of Schizophrenia during Pregnancy , 2012, Drugs.
[4] J. Bobes,et al. Change in psychiatrists’ attitudes towards the physical health care of patients with schizophrenia coinciding with the dissemination of the consensus on physical health in patients with schizophrenia , 2011, European Psychiatry.
[5] C. Correll,et al. Metabolic and endocrine adverse effects of second-generation antipsychotics in children and adolescents: A systematic review of randomized, placebo controlled trials and guidelines for clinical practice , 2011, European Psychiatry.
[6] C. Correll,et al. Determinants of poor dental care in patients with schizophrenia: a historical, prospective database study. , 2011, The Journal of clinical psychiatry.
[7] H. Möller,et al. Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care , 2011, World psychiatry : official journal of the World Psychiatric Association.
[8] S. Kisely,et al. Inequalities in healthcare provision for people with severe mental illness , 2010, Journal of psychopharmacology.
[9] M. Mojarrad,et al. Effects of adopting a smoke-free policy in state psychiatric hospitals. , 2010, Psychiatric services.
[10] C. Correll,et al. Management of antipsychotic-related weight gain , 2010, Expert review of neurotherapeutics.
[11] S. Gilbody,et al. Smoking cessation in severe mental illness: what works? , 2010, Addiction.
[12] M. De Hert,et al. Physical health management in psychiatric settings , 2010, European Psychiatry.
[13] R. Drake,et al. WPA guidance on steps, obstacles and mistakes to avoid in the implementation of community mental health care , 2010, World psychiatry : official journal of the World Psychiatric Association.
[14] M. Maj. Mistakes to avoid in the implementation of community mental health care , 2010, World psychiatry : official journal of the World Psychiatric Association.
[15] H. Millar,et al. Development of a Health Screening Clinic , 2010, European Psychiatry.
[16] C. Correll,et al. Management of physical health in patients with schizophrenia: practical recommendations , 2010, European Psychiatry.
[17] C. Correll. From receptor pharmacology to improved outcomes: individualising the selection, dosing, and switching of antipsychotics , 2010, European Psychiatry.
[18] J. Bobes,et al. Healthy lifestyle habits and 10-year cardiovascular risk in schizophrenia spectrum disorders: An analysis of the impact of smoking tobacco in the CLAMORS schizophrenia cohort , 2010, Schizophrenia Research.
[19] A. Brown,et al. A retrospective evaluation of the impact of total smoking cessation on psychiatric inpatients taking clozapine , 2010, Acta psychiatrica Scandinavica.
[20] B. Druss,et al. The Health and Recovery Peer (HARP) Program: A peer-led intervention to improve medical self-management for persons with serious mental illness , 2010, Schizophrenia Research.
[21] M. Hasnain,et al. Metabolic Syndrome Associated with Schizophrenia and Atypical Antipsychotics , 2010, Current diabetes reports.
[22] Patients must be able to derive maximum benefit from a psychiatrist's medical skills and broad training , 2010, World psychiatry : official journal of the World Psychiatric Association.
[23] S. Hollins. Bridging a cultural divide within medicine: a role for psychiatrists? , 2010, World psychiatry : official journal of the World Psychiatric Association.
[24] B. Söderfeldt,et al. Oral health-related quality of life and dental status in an outpatient psychiatric population: a multivariate approach. , 2010, International journal of mental health nursing.
[25] B. Druss,et al. A randomized trial of medical care management for community mental health settings: the Primary Care Access, Referral, and Evaluation (PCARE) study. , 2010, The American journal of psychiatry.
[26] Jennifer F Wilson. Diabetic Ketoacidosis , 2010, Annals of Internal Medicine.
[27] B. Duncan,et al. Smoking, Smoking Cessation, and Risk for Type 2 Diabetes Mellitus , 2010, Annals of Internal Medicine.
[28] J. Bobes,et al. Impact of substance use on the physical health of patients with bipolar disorder , 2009, Acta psychiatrica Scandinavica.
[29] D. Vancampfort,et al. Cardiometabolic effects of physical activity interventions for people with schizophrenia , 2009 .
[30] P. Zimmet,et al. International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes , 2009, Diabetes Care.
[31] A. Simons,et al. Sexual dysfunction in depression and anxiety: conceptualizing sexual dysfunction as part of an internalizing dimension. , 2009, Clinical psychology review.
[32] Barbara Napolitano,et al. Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents. , 2009, JAMA.
[33] S. Grundy,et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International As , 2009, Circulation.
[34] Y. Frances,et al. Élaboration de recommandations pour le suivi somatique des patients atteints de pathologie mentale sévère , 2009 .
[35] H. Möller,et al. Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC) , 2009, European Psychiatry.
[36] J. Silversides,et al. Diabetic ketoacidosis guidelines and protection from aspiration pneumonitis , 2009, Diabetic medicine : a journal of the British Diabetic Association.
[37] J. Shaw,et al. International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes , 2009, Diabetes Care.
[38] R. Reeves,et al. Efficacy of behavioural interventions in managing atypical antipsychotic weight gain , 2009, Obesity reviews : an official journal of the International Association for the Study of Obesity.
[39] J. Kane. Creating a health care team to manage chronic medical illnesses in patients with severe mental illness: the public policy perspective. , 2009, The Journal of clinical psychiatry.
[40] A. Fagiolini,et al. The effects of undertreated chronic medical illnesses in patients with severe mental disorders. , 2009, The Journal of clinical psychiatry.
[41] L. Miller. Management of Atypical Antipsychotic Drug‐Induced Weight Gain: Focus on Metformin , 2009, Pharmacotherapy.
[42] N. Rüsch,et al. Self‐stigma and the “why try” effect: impact on life goals and evidence‐based practices , 2009, World psychiatry : official journal of the World Psychiatric Association.
[43] A. Einarson,et al. Use and Safety of Antipsychotic Drugs During Pregnancy , 2009, Journal of psychiatric practice.
[44] W. Riley,et al. Obesity among those with mental disorders: a National Institute of Mental Health meeting report. , 2009, American journal of preventive medicine.
[45] J. Newcomer,et al. Prevalence and predictors of lipid and glucose monitoring in commercially insured patients treated with second-generation antipsychotic agents. , 2009, The American journal of psychiatry.
[46] W. Fleischhacker,et al. Is second-generation antipsychotic-induced hyperprolactinemia due to biologically active prolactin or to biologically inactive macroprolactin? Results from a prospective study. , 2009, The Journal of clinical psychiatry.
[47] M. Maj. Physical health care in persons with severe mental illness: a public health and ethical priority , 2009, World psychiatry : official journal of the World Psychiatric Association.
[48] D. Vancampfort,et al. Metabolic syndrome in people with schizophrenia: a review , 2009, World psychiatry : official journal of the World Psychiatric Association.
[49] R. Kerwin. Connecting patient needs with treatment management , 2009, Acta psychiatrica Scandinavica. Supplementum.
[50] Bryan K. Smith,et al. American College of Sports Medicine Position Stand. Appropriate physical activity intervention strategies for weight loss and prevention of weight regain for adults. , 2009, Medicine and science in sports and exercise.
[51] A. Waterreus,et al. Screening for the metabolic syndrome in patients receiving antipsychotic treatment: a proposed algorithm , 2009, The Medical journal of Australia.
[52] P. Chanson,et al. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness]. , 2009, L'Encephale.
[53] M. González,et al. Consensus on physical health of patients with schizophrenia from the Spanish Societies of Psychiatry and Biological Psychiatry , 2008 .
[54] E. Elbogen,et al. Access to medical care among persons with psychotic and major affective disorders. , 2008, Psychiatric services.
[55] P. McGorry,et al. Non-pharmacological management of antipsychotic-induced weight gain: Systematic review and meta-analysis of randomised controlled trials , 2008, British Journal of Psychiatry.
[56] H. Millar. Management of physical health in schizophrenia: A stepping stone to treatment success , 2008, European Neuropsychopharmacology.
[57] J. Lieberman,et al. Comorbid somatic illnesses in patients with severe mental disorders: clinical, policy, and research challenges. , 2008, The Journal of clinical psychiatry.
[58] M. Baggaley. Sexual dysfunction in schizophrenia: focus on recent evidence , 2008, Human psychopharmacology.
[59] L. Citrome,et al. Antipsychotics and hyperprolactinaemia: Clinical recommendations , 2008, Journal of psychopharmacology.
[60] M. Rees,et al. Primary prevention of coronary heart disease in women , 2008, Menopause international.
[61] Shubulade Smith,et al. Categorical prevalence and severity of hyperprolactinaemia in two UK cohorts of patients with severe mental illness during treatment with antipsychotics , 2008, Journal of psychopharmacology.
[62] I. Jones,et al. Clinical questions and uncertainty — prolactin measurement in patients with schizophrenia and bipolar disorder , 2008, Journal of psychopharmacology.
[63] H. Wyatt,et al. International strategies to address obesity , 2008, Obesity reviews : an official journal of the International Association for the Study of Obesity.
[64] P. Mackin,et al. Cardiac side effects of psychiatric drugs , 2008, Human psychopharmacology.
[65] H. Brown. Implications for policy development , 2008 .
[66] J. Sáiz Ruiz,et al. [Consensus on physical health of patients with schizophrenia from the Spanish Societies of Psychiatry and Biological Psychiatry]. , 2008, Actas espanolas de psiquiatria.
[67] C. Ball,et al. Diabetic ketoacidosis and hyperglycaemic hyperosmolar syndrome - clinical guidelines. , 2008, Nursing in critical care.
[68] W. Cahn,et al. [Prevention and treatment of somatic complications arising from the use of antipsychotics]. , 2008, Tijdschrift voor psychiatrie.
[69] W. Alexander. American psychiatric association. , 2008, P & T : a peer-reviewed journal for formulary management.
[70] S. Goh,et al. Point-of-care blood ketone testing: screening for diabetic ketoacidosis at the emergency department. , 2007, Singapore medical journal.
[71] John Mahoney,et al. Barriers to improvement of mental health services in low-income and middle-income countries , 2007, The Lancet.
[72] Betty Vreeland. Treatment decisions in major mental illness: weighing the outcomes. , 2007, The Journal of clinical psychiatry.
[73] Shah Ebrahim,et al. Fourth Joint Task Force of the European Society of Cardiology and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) , 2007 .
[74] R. Conley,et al. Adjunctive treatment with a dopamine partial agonist, aripiprazole, for antipsychotic-induced hyperprolactinemia: a placebo-controlled trial. , 2007, The American journal of psychiatry.
[75] S. Chau,et al. Effects of service barriers on health status of older Chinese immigrants in Canada. , 2007, Social work.
[76] P. Mackin,et al. A prospective study of monitoring practices for metabolic disease in antipsychotic-treated community psychiatric patients , 2007, BMC psychiatry.
[77] A. Kilbourne,et al. Self-reported access to general medical and psychiatric care among veterans with bipolar disorder , 2007 .
[78] A. Heald,et al. Minimising metabolic and cardiovascular risk in schizophrenia: diabetes, obesity and dyslipidaemia , 2007, Journal of psychopharmacology.
[79] A. Kilbourne,et al. Datapoints: self-reported access to general medical and psychiatric care among veterans with bipolar disorder. , 2007, Psychiatric services.
[80] J. Newcomer,et al. Series introduction and cardiovascular disease in patients with schizophrenia. , 2007, The Journal of clinical psychiatry.
[81] J. Thakore,et al. Impaired glucose tolerance in first‐episode drug‐naïve patients with schizophrenia , 2007, Diabetic medicine : a journal of the British Diabetic Association.
[82] Betty Vreeland. Bridging the gap between mental and physical health: a multidisciplinary approach. , 2007, The Journal of clinical psychiatry.
[83] M. Sernyak. Implementation of monitoring and management guidelines for second-generation antipsychotics. , 2007, The Journal of clinical psychiatry.
[84] Richard Gray,et al. Serious mental illness and physical health problems: a discussion paper. , 2007, International journal of nursing studies.
[85] S. Riedel-Heller,et al. Health habits of patients with schizophrenia , 2007, Social Psychiatry and Psychiatric Epidemiology.
[86] G. Remington,et al. Interventions to reduce weight gain in schizophrenia. , 2007, Schizophrenia bulletin.
[87] A. Dominiczak,et al. 2007 ESH‐ESC Guidelines for the management of arterial hypertension , 2007 .
[88] T. Barnes,et al. A UK audit of screening for the metabolic side effects of antipsychotics in community patients. , 2006, Schizophrenia bulletin.
[89] C. Hennekens. Increasing global burden of cardiovascular disease in general populations and patients with schizophrenia. , 2007, The Journal of clinical psychiatry.
[90] H. Wyatt,et al. Small Changes: A Big Idea for Addressing Obesity , 2006 .
[91] M. De Hert,et al. Screening for diabetes and other metabolic abnormalities in patients with schizophrenia and schizoaffective disorder: evaluation of incidence and screening methods. , 2006, The Journal of clinical psychiatry.
[92] P. Sharan,et al. World Health Organization's Mental Health Atlas 2005:implications for policy development. , 2006, World psychiatry : official journal of the World Psychiatric Association.
[93] Dan M. Roden,et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines , 2006 .
[94] J. Lieberman,et al. Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: Data from the CATIE schizophrenia trial sample at baseline , 2006, Schizophrenia Research.
[95] C. Correll,et al. Endocrine and metabolic adverse effects of psychotropic medications in children and adolescents. , 2006, Journal of the American Academy of Child and Adolescent Psychiatry.
[96] J. Peuskens,et al. Usefulness of glycosylated haemoglobin (HbA1c) to screen for diabetes in patients with schizophrenia , 2006, Schizophrenia Research.
[97] M. Sernyak,et al. Metabolic Monitoring for Patients Treated with Antipsychotic Medications , 2006, Canadian journal of psychiatry. Revue canadienne de psychiatrie.
[98] M. Berk,et al. A Clinical Monitoring System for Clozapine , 2006, Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists.
[99] Harold Alan Pincus,et al. From silos to bridges: meeting the general health care needs of adults with severe mental illnesses. , 2006, Health affairs.
[100] Craig W. Colton,et al. Congruencies in Increased Mortality Rates, Years of Potential Life Lost, and Causes of Death Among Public Mental Health Clients in Eight States , 2006, Preventing chronic disease.
[101] M. DeHert,et al. Metabolic abnormalities associated with second generation antipsychotics: fact or fiction? Development of guidelines for screening and monitoring. , 2006 .
[102] M. Hert,et al. Metabolic abnormalities associated with second generation antipsychotics: fact or fiction? Development of guidelines for screening and monitoring. , 2006 .
[103] G. Remington,et al. Validation of a physical activity assessment tool for individuals with schizophrenia , 2006, Schizophrenia Research.
[104] R. Hirschfeld,et al. An open-label extension trial of risperidone monotherapy in the treatment of bipolar I disorder , 2006, International clinical psychopharmacology.
[105] Donald R. Miller,et al. Disparities in diabetes care: impact of mental illness. , 2005, Archives of internal medicine.
[106] C. Hennekens,et al. Schizophrenia and increased risks of cardiovascular disease. , 2005, American heart journal.
[107] J. Lieberman,et al. A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls , 2005, Schizophrenia Research.
[108] Paul Zimmet,et al. [A new international diabetes federation worldwide definition of the metabolic syndrome: the rationale and the results]. , 2005, Revista espanola de cardiologia.
[109] Del D. Miller,et al. Clinicians' recognition of the metabolic adverse effects of antipsychotic medications , 2005, Schizophrenia Research.
[110] L. Citrome,et al. Do guidelines for severe mental illness promote physical health and well-being? , 2005, Journal of psychopharmacology.
[111] JoAnn E Manson,et al. Epidemiological evidence for the role of physical activity in reducing risk of type 2 diabetes and cardiovascular disease. , 2005, Journal of applied physiology.
[112] M. Molitch. Medication-induced hyperprolactinemia. , 2005, Mayo Clinic proceedings.
[113] J. Leon,et al. A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors , 2005, Schizophrenia Research.
[114] D. King,et al. Exercise, insulin resistance, and hypertension: a complex relationship. , 2005, Metabolic syndrome and related disorders.
[115] J. Greening. Physical health of patients in rehabilitation and recovery: asurveyofcasenoterecords , 2005 .
[116] C. Correll,et al. Cost-effective screening for the metabolic syndrome in patients treated with second-generation antipsychotic medications. , 2005, The American journal of psychiatry.
[117] Peter Arner,et al. Use of waist circumference to predict insulin resistance: retrospective study , 2005, BMJ : British Medical Journal.
[118] M. De Hert,et al. Belgian consensus on metabolic problems associated with atypical antipsychotics , 2005, International journal of psychiatry in clinical practice.
[119] Shah Ebrahim,et al. European guidelines on cardiovascular disease prevention in clinical practice , 2004 .
[120] A. Dhar,et al. National Institute for Health and Clinical Excellence , 2005 .
[121] J. Newcomer,et al. The Atypical Antipsychotic Therapy and Metabolic Issues National Survey: Practice Patterns and Knowledge of Psychiatrists , 2004, Journal of clinical psychopharmacology.
[122] C. Paton,et al. Obesity, dyslipidaemias and smoking in an inpatient population treated with antipsychotic drugs , 2004, Acta psychiatrica Scandinavica.
[123] C. Stokes,et al. Dietary sugar and polyunsaturated fatty acid consumption as predictors of severity of schizophrenia symptoms. , 2004, Nutritional neuroscience.
[124] John M Davis,et al. Physical health monitoring of patients with schizophrenia. , 2004, The American journal of psychiatry.
[125] F. Dickerson,et al. Comorbidity of Medical Illnesses Among Adults With Serious Mental Illness Who Are Receiving Community Psychiatric Services , 2004, The Journal of nervous and mental disease.
[126] J. Fudge,et al. From Galactorrhea to Osteopenia: Rethinking Serotonin–Prolactin Interactions , 2004, Neuropsychopharmacology.
[127] S. Minsky,et al. Managing atypical antipsychotic-associated weight gain: 12-month data on a multimodal weight control program. , 2004, The Journal of clinical psychiatry.
[128] R. McCreadie,et al. Diet, smoking and cardiovascular risk in people with schizophrenia: descriptive study. , 2003, The British journal of psychiatry : the journal of mental science.
[129] R. Bergman,et al. Insulin sensitivity, insulin secretion, and abdominal fat: the Insulin Resistance Atherosclerosis Study (IRAS) Family Study. , 2003, Diabetes.
[130] S. Minsky,et al. A program for managing weight gain associated with atypical antipsychotics. , 2003, Psychiatric services.
[131] Daniel W. Jones,et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.
[132] C. Pantelis,et al. Medical comorbidity in schizophrenia , 2003, The Medical journal of Australia.
[133] E. Yano,et al. Use of general medical services by VA patients with psychiatric disorders. , 2002, Psychiatric services.
[134] T. George,et al. A placebo controlled trial of bupropion for smoking cessation in schizophrenia , 2002, Biological Psychiatry.
[135] B. Druss,et al. Quality of Preventive Medical Care for Patients With Mental Disorders , 2002, Medical care.
[136] B. Druss,et al. Quality of medical care and excess mortality in older patients with mental disorders. , 2001, Archives of general psychiatry.
[137] J M Dekker,et al. Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: The Hoorn Study. , 2001, JAMA.
[138] R. Buchanan,et al. Effects of sustained-release bupropion and supportive group therapy on cigarette consumption in patients with schizophrenia. , 2001, The American journal of psychiatry.
[139] M. Phelan,et al. Physical health of people with severe mental illness , 2001, BMJ : British Medical Journal.
[140] D. Ziedonis,et al. Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia. , 2000, The American journal of psychiatry.
[141] B. Barraclough,et al. Causes of the excess mortality of schizophrenia. , 2000, The British journal of psychiatry : the journal of mental science.
[142] J. Birtwistle,et al. The unhealthy lifestyle of people with schizophrenia , 1999, Psychological Medicine.
[143] L. Goldman. Medical illness in patients with schizophrenia. , 1999, The Journal of clinical psychiatry.
[144] J. Addington,et al. Smoking cessation treatment for patients with schizophrenia. , 1998, The American journal of psychiatry.
[145] T. Burns,et al. Item-of-service payments for general practitioner care of severely mentally ill persons: does the money matter? , 1998, The British journal of general practice : the journal of the Royal College of General Practitioners.
[146] C. Hennekens. Increasing burden of cardiovascular disease: current knowledge and future directions for research on risk factors. , 1998, Circulation.
[147] T. Kendrick,et al. Cardiovascular and Respiratory Risk Factors and Symptoms among General Practice Patients with Long-Term Mental Illness , 1996, British Journal of Psychiatry.
[148] D. Jeste,et al. Medical comorbidity in schizophrenia. , 1996, Schizophrenia bulletin.
[149] J. Manson,et al. The primary prevention of coronary heart disease in women. , 1995, The New England journal of medicine.
[150] L. Shaw,et al. The effectiveness of differing dental health education programmes in improving the oral health of adults with mental handicaps attending Birmingham adult training centres. , 1991, Community dental health.
[151] North American Association for the Study of Obesity , 1991, International journal of obesity.
[152] Brian L. Smith,et al. Physical Health of the Long-Term Mentally Ill in the Community , 1989, British Journal of Psychiatry.
[153] J. Ananth. Physical illness and psychiatric disorders. , 1984, Comprehensive psychiatry.